The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Self-assembled nanoscale coordination polymers with trigger release properties for effective anticancer therapy
Open accessAbstract
Nanoscale coordination polymers (NCPs) are self-assembled from metal ions and organic bridging ligands, and can overcome many drawbacks of existing drug delivery systems by virtue of tunable compositions, sizes and shapes, high drug loadings, ease of surface modification and intrinsic biodegradability. Here we report the self-assembly of zinc bisphosphonate NCPs that carry 48±3 wt% cisplatin prodrug and 45±5 wt% oxaliplatin prodrug. In vivo pharmacokinetic studies in mice show minimal uptake of pegylated NCPs by the mononuclear phagocyte system and excellent blood circulation half-lives of 16.4±2.9 and 12.0±3.9 h for the NCPs carrying cisplatin and oxaliplatin, respectively. In all tumour xenograft models evaluated, including CT26 colon cancer, H460 lung cancer and AsPC-1 pancreatic cancer, pegylated NCPs show superior potency and efficacy compared with free drugs. As the first example of using NCPs as nanotherapeutics with enhanced antitumour activities, this study establishes NCPs as a promising drug delivery platform for cancer therapy. Nanoscale coordination polymers are promising materials for use as drug delivery nanoparticles, as their structural properties can be easily and precisely controlled to influence drug loading and release. Here, the authors present such a structure for effective in vivoanticancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Scagliotti, G. V., Parikh, P., von Pawel, J., Biesma, B., Vansteenkiste, J., Manegold, C., Serwatowski, P., Gatzemeier, U., Digumarti, R., Zukin, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0375 · Cited by 3,203
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M. R., Miyazono, K., Uesaka, M., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.166 · Cited by 2,429
Cabral, H., Nishiyama, N., Okazaki, S., Koyama, H., & Kataoka, K. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.022 · Cited by 201
Cited by
Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00597 · Cited by 2,485
He, C., Liu, D., & Lin, W. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00125 · Cited by 1,001
Self-citationMetal complexes in cancer therapy – an update from drug design perspective
Ndagi, U., Mhlongo, N., & Soliman, M. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s119488 · Cited by 935
Metal–Organic Framework Nanoparticles
Wang, S., McGuirk, C. M., d'Aquino, A., Mason, J. A., & Mirkin, C. A. (2018) · Advanced Materials · doi:10.1002/adma.201800202 · Cited by 833
Sun, X., Zhang, Y., Li, J., Park, K. S., Han, K., Zhou, X., Xu, Y., Nam, J., Xu, J., Shi, X., et al. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00962-9 · Cited by 788
He, C., Duan, X., Guo, N., Chan, C., Poon, C., Weichselbaum, R. R., & Lin, W. (2016) · Nature Communications · doi:10.1038/ncomms12499 · Cited by 754
Self-citationNanoscale Metal–Organic Frameworks for Therapeutic, Imaging, and Sensing Applications
Lu, K., Aung, T., Guo, N., Weichselbaum, R., & Lin, W. (2018) · Advanced Materials · doi:10.1002/adma.201707634 · Cited by 692
Self-citation1D Coordination Polymer Nanofibers for Low‐Temperature Photothermal Therapy
Yang, Y., Zhu, W., Dong, Z., Chao, Y., Xu, L., Chen, M., & Liu, Z. (2017) · Advanced Materials · doi:10.1002/adma.201703588 · Cited by 583
Postsynthetic Modification: An Enabling Technology for the Advancement of Metal–Organic Frameworks
Kalaj, M., & Cohen, S. M. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00690 · Cited by 556
Nanoscale metal–organic frameworks for drug delivery: a conventional platform with new promise
Wang, L., Zheng, M., & Xie, Z. (2018) · Journal of Materials Chemistry B · doi:10.1039/c7tb02970e · Cited by 505
Nanoscale metal−organic frameworks for combined photodynamic & radiation therapy in cancer treatment
Liu, J., Yang, Y., Zhu, W., Yi, X., Dong, Z., Xu, X., Chen, M., Yang, K., Lu, G., Jiang, L., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.034 · Cited by 447
Ren, Z., Sun, S., Sun, R., Cui, G., Hong, L., Rao, B., Li, A., Yu, Z., Kan, Q., & Mao, Z. (2020) · Advanced Materials · doi:10.1002/adma.201906024 · Cited by 446
Chemophototherapy: An Emerging Treatment Option for Solid Tumors
Luo, D., Carter, K. A., Miranda, D., & Lovell, J. F. (2017) · Advanced Science · doi:10.1002/advs.201600106 · Cited by 436
Supramolecular cancer nanotheranostics
Zhou, J., Rao, L., Yu, G., Cook, T. R., Chen, X., & Huang, F. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00011f · Cited by 411
The Chemistry of Reticular Framework Nanoparticles: MOF, ZIF, and COF Materials
Ploetz, E., Engelke, H., Lächelt, U., & Wuttke, S. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909062 · Cited by 350
Yang, Y., Liu, J., Liang, C., Feng, L., Fu, T., Dong, Z., Chao, Y., Li, Y., Lu, G., Chen, M., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b07882 · Cited by 342
Lymph node targeting strategies to improve vaccination efficacy
Jiang, H., Wang, Q., & Sun, X. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.009 · Cited by 297
Liu, F., He, X., Chen, H., Zhang, J., Zhang, H., & Wang, Z. (2015) · Nature Communications · doi:10.1038/ncomms9003 · Cited by 295
Wuttke, S., Lismont, M., Escudero, A., Rungtaweevoranit, B., & Parak, W. J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.01.025 · Cited by 286
Dong, Z., Feng, L., Zhu, W., Sun, X., Gao, M., Zhao, H., Chao, Y., & Liu, Z. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.09.025 · Cited by 284
Metal-containing and related polymers for biomedical applications
Yan, Y., Zhang, J., Ren, L., & Tang, C. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00026f · Cited by 283
Metal-Organic Framework (MOF)-Based Drug Delivery
Cao, J., Li, X., & Tian, H. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867326666190618152518 · Cited by 282
An ultra-tunable platform for molecular engineering of high-performance crystalline porous materials
Zhai, Q.-G., Bu, X., Mao, C., Zhao, X., Daemen, L., Cheng, Y., Ramirez-Cuesta, A. J., & Feng, P. (2016) · Nature Communications · doi:10.1038/ncomms13645 · Cited by 279
He, C., Liu, D., & Lin, W. (2015) · ACS Nano · doi:10.1021/nn506963h · Cited by 274
Self-citationBai, J., Jia, X., Zhen, W., Cheng, W., & Jiang, X. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b11114 · Cited by 272
Multifunctional Efficiency: Extending the Concept of Atom Economy to Functional Nanomaterials
Freund, R., Lächelt, U., Gruber, T., Rühle, B., & Wuttke, S. (2018) · ACS Nano · doi:10.1021/acsnano.8b00932 · Cited by 262
A 3D-printed local drug delivery patch for pancreatic cancer growth suppression
Yi, H.-G., Choi, Y.-J., Kang, K. S., Hong, J. M., Pati, R. G., Park, M. N., Shim, I. K., Lee, C. M., Kim, S. C., & Cho, D.-W. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.015 · Cited by 260
Duan, X., Chan, C., Han, W., Guo, N., Weichselbaum, R. R., & Lin, W. (2019) · Nature Communications · doi:10.1038/s41467-019-09221-x · Cited by 256
Self-citationNanoparticle formulations of cisplatin for cancer therapy
Duan, X., He, C., Kron, S. J., & Lin, W. (2016) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1390 · Cited by 216
Self-citationHybrid nanoparticles for combination therapy of cancer
He, C., Lu, J., & Lin, W. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.029 · Cited by 174
Self-citationPhysical‐, chemical‐, and biological‐responsive nanomedicine for cancer therapy
Liao, J., Jia, Y., Wu, Y., Shi, K., Yang, D., Li, P., & Qian, Z. (2020) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1581 · Cited by 67
Metadata
- Authors
- Liu, D., Poon, C., Lu, K., He, C., & Lin, W.
- Venue
- Nature Communications
- Published
- 2014-06-25
- Volume
- 5
- Issue
- 1
- Pages
- 4182-4182
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2041648514
- Cited by
- 251
- References
- 9
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.